Competition for microtubule-binding with dual expression of tau missense and splice isoforms.

How tau mutations lead to neurodegeneration is unknown but may be related to altered microtubule binding properties of mutant tau protein. The tendency for the mutations to cluster around the microtubule-binding domain of tau or to alter the ratios of those splice isoforms that affect binding supports the view that the tau/microtubule interaction is critical and finely regulated. In cells transfected with both mutant and wild-type tau isoforms fused to either yellow fluorescent protein or cyan fluorescent protein we can observe tau fusion proteins that differ by a single amino acid or by the inclusion or exclusion of exon 10. With coexpression of mutant and wild-type tau, the mutant isoform appears diffuse throughout the cytoplasm; however, when mutant tau is expressed alone, it appears mostly bound to the microtubules. Dual imaging of the three- and four-repeat tau isoforms indicated that the expression of four-repeat tau displaced three-repeat tau from the microtubules. These results suggest that altered kinetic competition among the isoforms for microtubule binding could be a disease precipitant.

[1]  M. Hutton.  Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms , 2001, Neurology.

[2]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[3]  D. Panda,et al.  Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M G Spillantini,et al.  Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[5]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Dickson,et al.  Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.

[7]  M. Hutton,et al.  Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.

[8]  S. Lovestone,et al.  Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation , 1999, FEBS letters.

[9]  J. Ávila,et al.  Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations , 1999, FEBS letters.

[10]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[11]  T. Tabira,et al.  FTDP‐17 mutations N279K and S305N in tau produce increased splicing of exon 10 , 1999, FEBS letters.

[12]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[13]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[15]  M. Goedert,et al.  Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.

[16]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[17]  A. Delacourte,et al.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation , 1998, Annals of neurology.

[18]  Kenneth H. Downing,et al.  Structure of the αβ tubulin dimer by electron crystallography , 1998, Nature.

[19]  S. Kaech,et al.  Cytoskeletal Plasticity in Cells Expressing Neuronal Microtubule-Associated Proteins , 1996, Neuron.

[20]  S. Feinstein,et al.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau. , 1995, Biochemistry.

[21]  M. Kirschner,et al.  The minimum GTP cap required to stabilize microtubules , 1994, Current Biology.

[22]  F. Gros,et al.  Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein Tau and tubulin. , 1994, Biochemistry.

[23]  S. Feinstein,et al.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau , 1994, The Journal of cell biology.

[24]  H. Murofushi.  [Microtubule-associated proteins]. , 1993, Seikagaku. The Journal of Japanese Biochemical Society.

[25]  A. Frankfurter,et al.  Characterization of posttranslational modifications in neuron-specific class III beta-tubulin by mass spectrometry. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Rossier,et al.  Posttranslational glutamylation of alpha-tubulin. , 1990, Science.

[27]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[28]  R. Neve,et al.  The microtubule binding domain of tau protein , 1989, Neuron.

[29]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[30]  R. Uitti,et al.  A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. , 2000, Neurology.

[31]  E. Nogales,et al.  Structure of the alpha beta tubulin dimer by electron crystallography. , 1998, Nature.

[32]  K. Kosik,et al.  Brain microtubule associated proteins : modifications in disease , 1997 .